{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:53:36Z","timestamp":1789102416157,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372111"],"award-info":[{"award-number":["82372111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404557"],"award-info":[{"award-number":["82404557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403687"],"award-info":[{"award-number":["82403687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114288","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:19:26Z","timestamp":1759421966000},"page":"114288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Microorganism delivery of cancer vaccines"],"prefix":"10.1016","volume":"388","author":[{"given":"Fei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114288_bb0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101979","article-title":"Toxicity management with combination chemotherapy and programmed death 1\/programmed death ligand 1 inhibitor therapy in advanced lung cancer","volume":"85","author":"Hoffner","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2025.114288_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","article-title":"Emerging concepts for immune checkpoint blockade-based combination therapies","volume":"33","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114288_bb0025","doi-asserted-by":"crossref","first-page":"1188049","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0030","article-title":"CAR-T cell therapy in hematological malignancies: current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0045","first-page":"911","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.114288_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144195","article-title":"A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells","volume":"131","author":"Veatch","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114288_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114288_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114288_bb0070","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114288_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114288_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri2587","article-title":"A cell biological view of toll-like receptor function: regulation through compartmentalization","volume":"9","author":"Barton","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","article-title":"Innate immune sensing and signaling of cytosolic nucleic acids","volume":"32","author":"Wu","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2014.12.012","article-title":"Viral RNA detection by RIG-I-like receptors","volume":"32","author":"Yoneyama","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2013.04.004","article-title":"Innate immune detection of microbial nucleic acids","volume":"21","author":"G\u00fcrtler","year":"2013","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.coviro.2011.11.004","article-title":"Cytosolic surveillance and antiviral immunity","volume":"1","author":"Rathinam","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0105","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.184.4.1413","article-title":"Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo","volume":"184","author":"De Smedt","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114288_bb0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature07750","article-title":"Identification of a dendritic cell receptor that couples sensing of necrosis to immunity","volume":"458","author":"Sancho","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114288_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41590-020-00824-x","article-title":"The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens","volume":"22","author":"Canton","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114288_bb0130","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114288_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114288_bb0155","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114288_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","article-title":"Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth","volume":"5","author":"Zagato","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0165","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1038\/s41467-023-41768-8","article-title":"Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung","volume":"14","author":"Moreo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114288_bb0170","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41467-023-42135-3","article-title":"NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114288_bb0175","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1021\/acssynbio.1c00097","article-title":"Engineered attenuated Salmonella typhimurium expressing neoantigen has anticancer effects","volume":"10","author":"Hyun","year":"2021","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0180","article-title":"Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-Photothermal therapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114288_bb0185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001621","article-title":"Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma","volume":"9","author":"Malvehy","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0195","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jamcollsurg.2018.12.027","article-title":"Real-world outcomes of talimogene laherparepvec therapy: a multi-institutional experience","volume":"228","author":"Louie","year":"2019","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.jconrel.2025.114288_bb0200","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1073\/pnas.1303060110","article-title":"Hypoxia induces a phase transition within a kinase signaling network in cancer cells","volume":"110","author":"Wei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114288_bb0215","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/anie.201611783","article-title":"Anaerobe-inspired anticancer nanovesicles","volume":"56","author":"Qian","year":"2017","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114288_bb0220","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/1751-7915.13523","article-title":"Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy","volume":"13","author":"Yu","year":"2020","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0225","doi-asserted-by":"crossref","first-page":"2186114","DOI":"10.1080\/19490976.2023.2186114","article-title":"Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jconrel.2025.114288_bb0230","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114288_bb0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2019.10.033","article-title":"Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium","volume":"469","author":"Guo","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114288_bb0240","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1158\/0008-5472.CAN-06-2618","article-title":"Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis","volume":"67","author":"Kasinskas","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114288_bb0245","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1158\/1078-0432.CCR-07-1528","article-title":"Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114288_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031106","article-title":"STAT3\/5 inhibitors suppress proliferation in bladder cancer and enhance oncolytic adenovirus therapy","volume":"21","author":"Hindupur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114288_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.omto.2020.01.001","article-title":"The PERK inhibitor GSK2606414 enhances Reovirus infection in head and neck squamous cell carcinoma via an ATF4-dependent mechanism","volume":"16","author":"McLaughlin","year":"2020","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0260","doi-asserted-by":"crossref","first-page":"E4504","DOI":"10.1073\/pnas.1408759111","article-title":"Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers","volume":"111","author":"Lin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","article-title":"Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114288_bb0280","first-page":"2295","article-title":"Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant","volume":"38","author":"Lapointe","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114288_bb0285","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0290","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004529","article-title":"Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer","volume":"32","author":"Zheng","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114288_bb0300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jare.2023.04.002","article-title":"Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis","volume":"56","author":"Chen","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2025.114288_bb0305","doi-asserted-by":"crossref","first-page":"2003572","DOI":"10.1002\/advs.202003572","article-title":"Bacteria-based cancer immunotherapy","volume":"8","author":"Huang","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114295","article-title":"Advances in Salmonella typhimurium-based drug delivery system for cancer therapy","volume":"185","author":"Chen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114288_bb0315","doi-asserted-by":"crossref","first-page":"eabc1600","DOI":"10.1126\/scitranslmed.abc1600","article-title":"Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice","volume":"14","author":"Selvanesan","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0320","doi-asserted-by":"crossref","first-page":"1038807","DOI":"10.3389\/fimmu.2022.1038807","article-title":"Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma","volume":"13","author":"Oladejo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0325","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1073\/pnas.1211287110","article-title":"Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer","volume":"110","author":"Quispe-Tintaya","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0330","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1038\/s41467-021-26956-8","article-title":"Aptamer-assisted tumor localization of bacteria for enhanced biotherapy","volume":"12","author":"Geng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114288_bb0335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202719119","article-title":"Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth","volume":"119","author":"Ahmed","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0340","doi-asserted-by":"crossref","first-page":"1293351","DOI":"10.3389\/fcimb.2023.1293351","article-title":"Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment","volume":"13","author":"P\u00e9rez Jorge","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0345","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.1073\/pnas.0406035101","article-title":"Listeria-based cancer vaccines that segregate immunogenicity from toxicity","volume":"101","author":"Brockstedt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrmicro.2017.126","article-title":"Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis","volume":"16","author":"Radoshevich","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642316","article-title":"Clinical experience and recent advances in the development of Listeria-based tumor immunotherapies","volume":"12","author":"Oladejo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fcimb.2014.00051","article-title":"Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy","volume":"4","author":"Wood","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0365","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/s41598-021-92875-9","article-title":"Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model","volume":"11","author":"Su","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114288_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12010060","article-title":"A structural study on the Listeria monocytogenes Internalin A-human E-cadherin interaction: a molecular tool to investigate the effects of missense mutations","volume":"12","author":"Dellafiora","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0375","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tim.2012.04.006","article-title":"Listeriolysin O: the Swiss army knife of Listeria","volume":"20","author":"Hamon","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0380","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.180.6.2209","article-title":"Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes","volume":"180","author":"Ikonomidis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0385","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28926","article-title":"Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis","volume":"3","author":"Lizotte","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.114288_bb0390","doi-asserted-by":"crossref","first-page":"2260620","DOI":"10.1080\/2162402X.2023.2260620","article-title":"Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection","volume":"12","author":"Anderson","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.114288_bb0395","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12915-024-01876-3","article-title":"Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway","volume":"22","author":"Zhang","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114124","article-title":"The combined immunization of cervical cancer therapeutic vaccine based on Listeria balanced lethal system has a significant therapeutic effect on tumor model mice","volume":"148","author":"Ou","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.855759","article-title":"T-cell responses to Immunodominant Listeria epitopes limit vaccine-directed responses to the colorectal cancer antigen, Guanylyl Cyclase C","volume":"13","author":"Flickinger","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0410","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12915-024-02086-7","article-title":"LADS: a powerful vaccine platform for cancer immunotherapy and prevention","volume":"22","author":"Sun","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0415","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2024.09.006","article-title":"Advancements of engineered live oncolytic biotherapeutics (microbe\/virus\/cells): preclinical research and clinical progress","volume":"375","author":"Qi","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114288_bb0425","doi-asserted-by":"crossref","first-page":"20083","DOI":"10.1038\/s41598-021-99425-3","article-title":"Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114288_bb0430","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00262-020-02652-2","article-title":"Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model","volume":"69","author":"Stegantseva","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.114288_bb0435","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/srep00436","article-title":"Explicit hypoxia targeting with tumor suppression by creating an \u201cobligate\u201d anaerobic Salmonella typhimurium strain","volume":"2","author":"Yu","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114288_bb0440","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-015-0196-3","article-title":"Genetically modified \u201cobligate\u201d anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma","volume":"8","author":"Guo","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0445","article-title":"Tumor temporal proteome profiling reveals the immunological triple offensive induced by synthetic anti-cancer Salmonella","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0450","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0455","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/glia.20512","article-title":"Bacteria and PAMPs activate nuclear factor kappaB and Gro production in a subset of olfactory ensheathing cells and astrocytes but not in Schwann cells","volume":"55","author":"Vincent","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2025.114288_bb0460","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1021\/acsnano.3c02373","article-title":"Tuning bacterial morphology to enhance anticancer vaccination","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114288_bb0465","article-title":"Engineered probiotic-based personalized cancer vaccine potentiates antitumor immunity through initiating trained immunity","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0470","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1016\/j.vaccine.2021.08.028","article-title":"Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration","volume":"39","author":"Naciute","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114288_bb0475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114288_bb0480","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13099-023-00543-2","article-title":"Emerging role of bacterial outer membrane vesicle in gastrointestinal tract","volume":"15","author":"Tian","year":"2023","journal-title":"Gut Pathog."},{"key":"10.1016\/j.jconrel.2025.114288_bb0485","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0490","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.actbio.2019.04.033","article-title":"Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8(+) T cells","volume":"91","author":"Schetters","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114288_bb0495","doi-asserted-by":"crossref","first-page":"255","DOI":"10.20517\/evcna.2023.21","article-title":"Opportunities for engineering outer membrane vesicles using synthetic biology approaches","volume":"4","author":"Kelwick","year":"2023","journal-title":"Extracell Vesicles Circ. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2025.114288_bb0500","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/thno.85917","article-title":"Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors","volume":"14","author":"Zheng","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114288_bb0505","doi-asserted-by":"crossref","first-page":"18716","DOI":"10.1021\/acsnano.3c01912","article-title":"Redirecting antigens by engineered photosynthetic bacteria and derived outer membrane vesicles for enhanced cancer immunotherapy","volume":"17","author":"Han","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114288_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113283","article-title":"Recombinant ClearColi\u2122-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma","volume":"143","author":"Sharif","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0515","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41467-021-22308-8","article-title":"Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology","volume":"12","author":"Cheng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114288_bb0520","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41551-022-00886-2","article-title":"Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria","volume":"6","author":"Yue","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114288_bb0525","article-title":"Rapid surface display of mRNA antigens by bacteria-derived outer membrane vesicles for a personalized tumor vaccine","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114288_bb0530","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114288_bb0535","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","article-title":"Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits","volume":"1","author":"Cichon","year":"1999","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0540","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009644","article-title":"Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8(+) T cell control of tumor challenge in mice","volume":"12","author":"Dagotto","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0545","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009869","article-title":"Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors","volume":"12","author":"Zhu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0550","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71156","article-title":"A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines","volume":"11","author":"Feola","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2025.114288_bb0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010521","article-title":"Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma","volume":"13","author":"Zheng","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0560","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-019-10594-2","article-title":"Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade","volume":"10","author":"D\u2019Alise","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114288_bb0565","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development","volume":"97","author":"Volz","year":"2017","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jconrel.2025.114288_bb0570","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221166","article-title":"OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs","volume":"220","author":"Yang","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007336","article-title":"Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer","volume":"11","author":"Brito Baleeiro","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0580","doi-asserted-by":"crossref","first-page":"1050250","DOI":"10.3389\/fimmu.2022.1050250","article-title":"CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX","volume":"13","author":"Whelan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0585","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s42003-020-01374-6","article-title":"Rapid poxvirus engineering using CRISPR\/Cas9 as a selection tool","volume":"3","author":"Gowripalan","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007209","article-title":"A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors","volume":"14","author":"Leoni","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2025.114288_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.832393","article-title":"Utility of a recombinant HSV-1 vaccine vector for personalized cancer vaccines","volume":"9","author":"Uche","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114288_bb0600","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40425-019-0500-9","article-title":"Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection","volume":"7","author":"Beyranvand Nejad","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0605","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ymthe.2018.06.008","article-title":"Personalized cancer vaccine platform for clinically relevant oncolytic enveloped viruses","volume":"26","author":"Yl\u00f6sm\u00e4ki","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114288_bb0610","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.jconrel.2025.114288_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2022.109583","article-title":"Encapsidated-CpG ODN enhances immunogenicity of porcine circovirus type 2 virus-like particles","volume":"275","author":"Hansoongnern","year":"2022","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0620","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.02.031","article-title":"Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination","volume":"251","author":"Mohsen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114288_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122909","article-title":"Development of a virus-like particle-based anti-HER2 breast cancer vaccine","volume":"13","author":"Hu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002927","article-title":"Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma","volume":"10","author":"Mohsen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0635","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221859120","article-title":"Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis","volume":"120","author":"Chung","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114288_bb0640","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1021\/acsnano.4c07360","article-title":"Carbohydrate-lectin interactions reprogram dendritic cells to promote type 1 anti-tumor immunity","volume":"18","author":"Lensch","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114288_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120726","article-title":"P22 virus-like particles as an effective antigen delivery nanoplatform for cancer immunotherapy","volume":"271","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114288_bb0650","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.98579.3","article-title":"Engineering PEG10assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination","volume":"13","author":"Tang","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2025.114288_bb0655","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12935-023-02902-0","article-title":"Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired","volume":"23","author":"Marei","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.114288_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0665","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1412902","article-title":"TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade","volume":"7","author":"Cervera-Carrascon","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.114288_bb0670","doi-asserted-by":"crossref","first-page":"eabo7604","DOI":"10.1126\/scitranslmed.abo7604","article-title":"Adenoviral-based vaccine promotes neoantigen-specific CD8(+) T cell stemness and tumor rejection","volume":"14","author":"D\u2019Alise","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114288_bb0675","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005702","article-title":"First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)","volume":"11","author":"Autio","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0680","first-page":"706","article-title":"Chemotherapy","volume":"31","author":"Aiba","year":"2004","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.jconrel.2025.114288_bb0685","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/acschembio.4c00250","article-title":"Enhancing the anticancer activity of attenuated Listeria monocytogenes by cell wall functionalization with \u201cclickable\u201d doxorubicin","volume":"19","author":"Lepori","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114288_bb0690","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002374","article-title":"Phase I study of a multitargeted recombinant Ad5 PSA\/MUC-1\/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)","volume":"9","author":"Bilusic","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114288_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2017.01.004","article-title":"Radiotherapy for cancer: present and future","volume":"109","author":"Allen","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114288_bb0700","article-title":"Synergistic antitumor effect of combined radiotherapy and engineered Salmonella typhimurium in an intracranial sarcoma mouse model","volume":"11","author":"Liu","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2025.114288_bb0705","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00262-012-1257-x","article-title":"Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer","volume":"61","author":"Hannan","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.114288_bb0710","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:09:57Z","timestamp":1769868597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":142,"alternative-id":["S0168365925009010"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114288","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microorganism delivery of cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114288"}}